Categories
Archives
Receive Email Updates
-
-
Certified Licensing Professionals, Inc., 2021 Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
- About Me
Warren D. Woessner Pages
Archives
Tag Archives: Kubin
Happy Birthday Patents4Life – We Are 2!
Now some of them are not yet carved in judicial stone, being at various stages of appeal, but the sum of KSR, Bilski (well, I guess it was more pro-patent than the strict M or T test it replaced with … Continue reading
Posted in About SLW
Tagged Ariad, Ariad v. Lilly, Bilski, biotechnology, biotechnology law, biotechnology news, Federal Circuit, intellectual property, ip, IP law tools, KSR, Kubin, Lilly, Myriad, Patent Law, patents, Pharmaceutical law, Prometheus v. Mayo, stem cells, Supreme Court, Warren Woessner
1 Comment
AUTM Panel To Address A “Myriad” Of Challenges
Robert S. MacWright, J.D., Ph.D., the new head of tech transfer at the Salk Institute, will moderate a panel at the 2011 Annual Meeting of the Association of University Technology Managers (AUTM) on March 1st in Las Vegas. The panel, … Continue reading
Federal Circuit Mows Down Bean Patent – Reading Between the Rows
On July 10, 2009, the Court of Appeals for the Federal Circuit in In re Pod-Ners, Appeal No. 2008-1492, affirmed the Board’s rejection of all of the claims of U.S. Pat. No. 5,894,079. The Board had rejected as obvious claims … Continue reading
Kubin Analysis Continued
My last post began a rather selective analysis of In re Kubin, which the Federal Circuit decided on April 3, 2009 (see previous post for citations to this and related decisions). Kubin’s claims to DNA molecules encoding sequences including that … Continue reading
Posted in Obviousness
Tagged biotechnology, Federal Circuit, Goodwin, Hoeksema, Kubin, Lilly vs. UC, patent attorney, patent gap, patents, valiente, Warren Woessner
Leave a comment